Fresh Versus Freeze-only After CAPA IVM on PCOS Patients
Launched by MỸ ĐỨC HOSPITAL · Mar 3, 2020
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
IVM (in vitro maturation) has been proved to be a more friendly treatment protocol for PCOS (polycystic ovary syndrome) patients compared with conventional controlled ovarian stimulation, with less complications (especially ovarian hyperstimulation syndrome), shorter treatment duration, lower cost, and acceptable pregnancy outcomes. CAPA (capacitation) IVM without hCG (human chorionic gonadotropin) priming, has routinely been used at My Duc hospital for nearly 3 years to replace hCG-IVM (with hCG priming) because of absolutely synchronized oocyte maturation stage and better embryo results a...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with high AFC (≥24 Antral Follicles in Both Ovaries), including PCOS plus PCO or high AFC
- • Having indications for ART
- • Having ≤ 2 IVM/IVF attempts
- • Permanent resident in Vietnam
- • Agree to have fresh embryos transfer or freeze-only on day 3
- • Agree to have ≤ 2 embryos transferred
- • Not participating in another IVF study at the same time
- Exclusion Criteria:
- • Oocyte donation cycles
- • Pre-implantation genetic diagnosis (PGD) cycles
About Mỹ đức Hospital
Mỹ Đức Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on ethical practices and patient safety, the hospital collaborates with reputable research organizations and healthcare professionals to conduct studies across various therapeutic areas. Committed to excellence in clinical research, Mỹ Đức Hospital leverages its state-of-the-art facilities and experienced staff to contribute valuable insights that enhance medical knowledge and treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, Tan Binh, Vietnam
Ho Chi Minh City, , Vietnam
Patients applied
Trial Officials
Lan N Vuong, MD, PhD
Principal Investigator
Mỹ Đức Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials